PharmaCyte Biotech, Inc. — DEF 14A Filings
7 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by PharmaCyte Biotech, Inc. (PMCB), sorted by most recent first. Each row links to the full filing on EdgarLookup. PharmaCyte Biotech, Inc. has filed 7 DEF 14A documents with the SEC since 2001. To view all SEC filings by PharmaCyte Biotech, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
3
4
424B2
424B3
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DFAN14A
EFFECT
NT 10-K
NT 10-Q
NTN 10K
NTN 10Q
PRE 14A
PREC14A
S-3
S-3/A
S-3MEF
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001683168-26-001593 | Mar 9, 2026 | Mar 30, 2026 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001683168-25-007435 | Oct 6, 2025 | Oct 30, 2025 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001683168-25-001464 | Mar 10, 2025 | Apr 24, 2025 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001683168-24-001762 | Mar 27, 2024 | Apr 29, 2024 |
| DEF 14A | DEFINITIVE PROXY | 0001683168-23-005167 | Jul 31, 2023 | Aug 31, 2023 |
| DEF 14A | DEF 14A | 0001683168-23-003905 | Jun 5, 2023 | — |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001683168-22-008032 | Nov 25, 2022 | Dec 28, 2022 |